UCSF Researchers Identify Brain Protein CUL5 as Key in Disposing of Toxic Tau Clumps

Researchers at UC San Francisco (UCSF) have identified a brain protein, CUL5, that plays a role in disposing of toxic tau protein clumps associated with dementia. Neurons exhibiting higher levels of CUL5 demonstrated reduced vulnerability to Alzheimer's disease. This discovery offers insights into how some brain cells maintain resilience even in advanced stages of the disease and suggests potential new therapeutic strategies for neurodegeneration. The findings were published in the journal Cell on January 28.

Research Discovery and Mechanism

The research team, led by senior author Martin Kampmann, PhD, a professor at UCSF, with Avi Samelson, PhD, spearheading the work, identified CUL5 through a laboratory model. They developed human neurons in a petri dish that were engineered to produce tau clumps. Using CRISPR gene editing technology, the researchers individually disabled each of the cells' 20,000 genes to observe their effects on tau clump formation. This process revealed CUL5, which was found to tag tau for elimination before it could aggregate into clumps within the cells.

Confirmation in Human Brains

To validate these observations in human subjects, researchers analyzed data from the Seattle Alzheimer's Disease Brain Atlas, which contains brain samples from deceased Alzheimer's patients. This analysis indicated that brain cells demonstrating resistance to degeneration in these patients also contained high levels of CUL5, supporting its role in preventing tau clumping.

Additional Findings

The study also identified another set of genes influencing tau accumulation that are related to oxidative stress. Oxidative stress is a process that causes cellular damage and increases with age. Researchers observed that oxidative stress made tau more "sticky" and prone to clumping.

Implications for Future Research

The identification of CUL5 and its mechanism contributes to the field of dementia research by providing new targets for drug discovery.

Dr. Kampmann suggested that CUL5 is well-suited for eliminating tau and could potentially be a target for future therapies aimed at enhancing the brain's natural mechanisms for avoiding neurodegeneration.